Stroke and Hepatotoxicity
Summary:
Hepatotoxicity is found among people with Stroke, especially for people who are female, 60+ old.
The study analyzes which people have Hepatotoxicity with Stroke. It is created by eHealthMe based on reports of 26 people who have Stroke from the Food and Drug Administration (FDA), and is updated regularly. You can use the study as a second opinion to make health care decisions.
What is Stroke?
Stroke (sudden death of a portion of the brain cells due to a lack of oxygen) is found to be associated with 2,310 drugs and 3,029 conditions by eHealthMe. Check the latest studies of Stroke.
What is Hepatotoxicity?
Hepatotoxicity (chemical-driven liver damage) is found to be associated with 1,087 drugs and 1,249 conditions by eHealthMe. Check the latest studies of Hepatotoxicity.
26 people who have Stroke and Hepatotoxicity are studied.

Gender of people who have Stroke and experienced Hepatotoxicity *:
- female: 52 %
- male: 48 %
Age of people who have Stroke and experienced Hepatotoxicity *:
- 0-1: 0.0 %
- 2-9: 0.0 %
- 10-19: 0.0 %
- 20-29: 0.0 %
- 30-39: 0.0 %
- 40-49: 0.0 %
- 50-59: 4 %
- 60+: 96 %
Common co-existing conditions for these people *:
- Atrial Fibrillation/flutter (atrial fibrillation and flutter are abnormal heart rhythms in which the atria, or upper chambers of the heart, are out of sync with the ventricles): 9 people, 34.62%
- High Blood Pressure: 5 people, 19.23%
- Macular Degeneration (painless eye condition that leads to the gradual loss of central vision): 5 people, 19.23%
- Infection: 4 people, 15.38%
- Urination - Excessive Volume: 2 people, 7.69%
- Pain: 2 people, 7.69%
- Cardiac Failure: 2 people, 7.69%
- High Blood Cholesterol: 2 people, 7.69%
- Hypersensitivity: 2 people, 7.69%
- Lung Cancer - Non-Small Cell (lung cancer): 2 people, 7.69%
Common drugs taken by these people *:
- Xarelto: 8 people, 30.77%
- Zopiclone: 5 people, 19.23%
- Ativan: 5 people, 19.23%
- Eliquis: 4 people, 15.38%
- Vaccinium Myrtillus: 3 people, 11.54%
- Insulin: 2 people, 7.69%
- Ursodeoxycholic Acid: 2 people, 7.69%
- Paracetamol: 2 people, 7.69%
- Aspirin: 1 person, 3.85%
- Atorvastatin Calcium: 1 person, 3.85%
Common symptoms for these people *:
- Anaemia (lack of blood): 7 people, 26.92%
- Diverticular Perforation (serious gastrointestinal condition in which the intestine's walls are perforated): 5 people, 19.23%
- Hepatitis (inflammation of the liver): 5 people, 19.23%
- Jaundice - Yellow Skin (a yellowish pigmentation of the skin): 3 people, 11.54%
- Fatigue (feeling of tiredness): 2 people, 7.69%
- Bleeding Disorders: 2 people, 7.69%
- Yellow Skin: 1 person, 3.85%
- Appetite - Decreased (decreased appetite occurs when you have a reduced desire to eat): 1 person, 3.85%
- Atrial Fibrillation/flutter (atrial fibrillation and flutter are abnormal heart rhythms in which the atria, or upper chambers of the heart, are out of sync with the ventricles): 1 person, 3.85%
- Bradycardia (abnormally slow heart action): 1 person, 3.85%
* Approximation only. Some reports may have incomplete information.
Do you take medications and have Hepatotoxicity?
- Check whether Hepatotoxicity is associated with a drug or a conditionRelated studies:
Treatments, associated drugs and conditions:
- Stroke (334,635 reports)
- Hepatotoxicity (23,823 reports)
All the drugs that are associated with Hepatotoxicity:
- Hepatotoxicity (1,087 drugs)
All the conditions that are associated with Hepatotoxicity:
- Hepatotoxicity (1,249 conditions)
How the study uses the data?
How to use the study?
DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.
The study is based on Hepatotoxicity and Stroke, and their synonyms.
Who is eHealthMe?
With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Could Guaifenesin cause Infusion Site Extravasation? - a second ago
- Could Citalopram Hydrobromide cause Bruxism Aggravated? - 6 seconds ago
- Could Pantethine cause Rashes? - 7 seconds ago
- Could Risperdal cause Confusional State? - 12 seconds ago
- Prempro vs. Activella, side effect and effectiveness comparison - 23 seconds ago
- Could Lansoprazole cause Catarrh? - 29 seconds ago
- Could Acetaminophen cause Upper Respiratory Tract Infection Bacterial? - 31 seconds ago
- Could Rifampin cause Tachypnea? - 32 seconds ago
- Microscopic Polyangiitis and Oxygen Saturation Decreased - 36 seconds ago
- Drug interactions of Ziac and Heparin - 38 seconds ago